Skip to main content

Comparative Diagnostic Accuracy of Point-of-Care Ultrasound for Detecting Reduced Left Ventricular Systolic Function: A Systematic Review and Meta-Analysis

In brief

Three bedside ultrasound methods detect reduced heart function with similar accuracy

Across 28 studies with 4,647 participants, visual assessment, a measurement called EPSS, and artificial intelligence-assisted ultrasound all showed moderate-to-high accuracy for identifying reduced left ventricular function. None performed significantly better than the others, even across operator experience levels; positive findings can help rule in reduced function, but formal echocardiography remains the reference test.

Journal
Journal of general internal medicine (Q1)
Published
17 November 2026
Study design
Systematic review of cohort studies
Evidence level
Level 2, Moderate (CEBM 2a)
Authors
Misha A Khan, Richard A Shellenberger, Ian R Ross, Yash B Patel, Alycia C Bellino, Mohammed El Nayir, et al.
PMID
43045903
DOI
10.1007/s11606-026-10980-9

Why clinicians should know about it

  • Picked for Internal Medicine (paper of the day, 20 November 2026): POCUS diagnostic accuracy for reduced LV function supports bedside assessment

Abstract

OBJECTIVE: To assess the diagnostic accuracy of point-of-care ultrasound (POCUS) for detecting reduced left ventricular systolic function (LVSF) using visual qualitative assessment (VQA), E-point septal separation (EPSS), and artificial intelligence (AI)-assisted assessment, compared with transthoracic echocardiography (TTE). METHODS: We searched PubMed, Ovid MEDLINE, Embase, and the Cochrane Library from January 1, 1985, through July 8, 2025. Eligible studies compared POCUS-assessed LVSF with left ventricular ejection fraction measured by TTE (or cardiac MRI in one study). Data were pooled using random-effects meta-analysis to determine the diagnostic odds ratio (DOR) and likelihood ratios (LR) for each of the three methods. RESULTS: Twenty-eight studies, including 4,647 participants, met inclusion criteria. Nine studies evaluating VQA yielded a DOR of 40.53 (95% CI, 15.07 to 109.00; P < 0.001) and a positive LR (LR + ) of 6.90 (95% CI, 3.75 to 12.69). Seven studies evaluating EPSS resulted in a DOR of 21.77 (95% CI, 10.25 to 46.28; P < 0.001) and a LR + of 5.70 (95% CI, 2.89 to 11.22). Five studies evaluating AI-assisted POCUS resulted in a DOR of 47.35 (95% CI, 16.87 to 132.93; P < 0.001) and a LR + of 8.37 (95% CI, 4.40 to 15.93). Meta-regression analyses revealed no statistically significant differences in diagnostic performance among the three methods. Subgroup analysis by operator experience level also showed no statistically significant difference between novice and experienced operators for each method. CONCLUSIONS: VQA, EPSS, and AI-assisted POCUS all demonstrate moderate-to-high diagnostic accuracy for identifying reduced LVSF, with no significant differences among methods on meta-regression or by operator experience level. Moderately strong LR + across all three methods supports the use of POCUS for ruling in reduced LVSF. EPSS cutoffs at the lower and upper ends of the reported range showed higher sensitivity and specificity, respectively, suggesting utility as a rule-in or rule-out tool where formal echocardiography is not readily available. REGISTRATION: PROSPERO CRD42024626542.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.